Andrew K.L. Goey
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 4
- Oncology top 10%
- Cancer Treatment and Pharmacology 5
- Biotechnology top 10%
-
- Herbal Medicine Research Studies 4
- Complementary and Alternative Medicine Studies 4
- Toxicology top 10%
-
- Cancer therapeutics and mechanisms 7
- Histone Deacetylase Inhibitors Research 4
-
- HIV/AIDS drug development and treatment 4
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Ron H.J. MathijssenRon H. N. van SchaikSander BinsFemke M. de ManJos H. BeijnenWilliam D. FiggJan H.M. SchellensIrma Meijerman
- Cited by
- PharmacologyOncologyBiotechnology
- Journals
- Journal of the American Chemical Society (1 paper)Cancer Research (3 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesNetherlandsNew Zealand
In The Last Decade
Andrew K.L. Goey
35 papers receiving 932 citations
Peers
Comparison fields: 5 of 104
- Pharmacology 165
- Oncology 313
- Biotechnology 83
- Complementary and alternative medicine 75
- Toxicology 30
Countries citing papers authored by Andrew K.L. Goey
This map shows the geographic impact of Andrew K.L. Goey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew K.L. Goey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew K.L. Goey more than expected).
Fields of papers citing papers by Andrew K.L. Goey
This network shows the impact of papers produced by Andrew K.L. Goey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew K.L. Goey. The network helps show where Andrew K.L. Goey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew K.L. Goey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 6 | |
| 9 | 2018 | 289 | |
| 10 | 2016 | 47 | |
| 11 | 2016 | 12 | |
| 12 | 2015 | 25 | |
| 13 | 2014 | 24 | |
| 14 | 2014 | 18 | |
| 15 | 2013 | 13 | |
| 16 | 2012 | 12 | |
| 17 | 2010 | 53 | |
| 18 | 2010 | 7 | |
| 19 | [Dexrazoxane in anthracycline induced cardiotoxicity and extravasation]. | 2010 | 3 |
| 20 | 2009 | 64 |
About Andrew K.L. Goey
Andrew K.L. Goey is a scholar working on Complementary and alternative medicine, Oncology and Pharmacology, having authored 36 papers that have together received 950 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Cancer Treatment and Pharmacology (5 papers), Herbal Medicine Research Studies (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Histone Deacetylase Inhibitors Research (4 papers), HIV/AIDS drug development and treatment (4 papers), Complementary and Alternative Medicine Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Pharmacology (165 citations), Oncology (313 citations) and Biotechnology (83 citations). Andrew K.L. Goey has collaborated with scholars based in United States, Netherlands and New Zealand. Frequent co-authors include Ron H.J. Mathijssen, Ron H. N. van Schaik, Sander Bins, Femke M. de Man, Jos H. Beijnen, William D. Figg, Jan H.M. Schellens, Irma Meijerman, Tristan M. Sissung and Martin P. Paulus. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.